Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.

Winn B, Tavares R, Fanion J, Noble L, Gao J, Sabo E, Resnick MB.

Hum Pathol. 2009 Mar;40(3):398-404. doi: 10.1016/j.humpath.2008.08.014. Epub 2008 Nov 7.

PMID:
18992917
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas.

Winn B, Tavares R, Matoso A, Noble L, Fanion J, Waldman SA, Resnick MB.

Hum Pathol. 2010 Jan;41(1):123-8. doi: 10.1016/j.humpath.2009.07.009. Epub 2009 Oct 1.

PMID:
19800103
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.

Groisman GM, Meir A, Sabo E.

Int J Gynecol Pathol. 2004 Jan;23(1):52-7.

PMID:
14668551
[PubMed - indexed for MEDLINE]
4.

Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon.

Hinoi T, Tani M, Lucas PC, Caca K, Dunn RL, Macri E, Loda M, Appelman HD, Cho KR, Fearon ER.

Am J Pathol. 2001 Dec;159(6):2239-48.

PMID:
11733373
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.

Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.

Jpn J Clin Oncol. 2010 Mar;40(3):208-13. doi: 10.1093/jjco/hyp150. Epub 2009 Nov 18.

PMID:
19926591
[PubMed - indexed for MEDLINE]
Free Article
6.

Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.

Kumari N, Prabha K, Singh RK, Baitha DK, Krishnani N.

Hum Pathol. 2013 Oct;44(10):2213-9. doi: 10.1016/j.humpath.2013.05.003. Epub 2013 Jul 5.

PMID:
23834763
[PubMed - indexed for MEDLINE]
8.

Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.

Fan Z, Li J, Dong B, Huang X.

Clin Cancer Res. 2005 Sep 1;11(17):6162-70.

PMID:
16144916
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

CDX2 expression in cutaneous metastatic carcinomas and extramammary Paget's Disease.

Lora V, Kanitakis J.

Anticancer Res. 2009 Dec;29(12):5033-7. Erratum in: Anticancer Res. 2010 Jan;30(1):277. Anticancer Res. 2010 Mar;30(3):1033.

PMID:
20044613
[PubMed - indexed for MEDLINE]
Free Article
11.

CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium.

Hinoi T, Gesina G, Akyol A, Kuick R, Hanash S, Giordano TJ, Gruber SB, Fearon ER.

Gastroenterology. 2005 Apr;128(4):946-61.

PMID:
15825077
[PubMed - indexed for MEDLINE]
12.

Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.

Mizoshita T, Tsukamoto T, Inada K, Ogasawara N, Hirata A, Kato S, Joh T, Itoh M, Yamamura Y, Tatematsu M.

Pathol Int. 2004 Jun;54(6):392-400.

PMID:
15144397
[PubMed - indexed for MEDLINE]
13.

Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.

Paner GP, McKenney JK, Barkan GA, Yao JL, Frankel WL, Sebo TJ, Shen SS, Jimenez RE.

Am J Surg Pathol. 2011 Jun;35(6):787-98. doi: 10.1097/PAS.0b013e3182189c11.

PMID:
21572312
[PubMed - indexed for MEDLINE]
14.

Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.

Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R.

Mod Pathol. 2008 Feb;21(2):192-200. Epub 2007 Dec 14.

PMID:
18084247
[PubMed - indexed for MEDLINE]
Free Article
15.

Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.

Puglisi F, Cesselli D, Damante G, Pellizzari L, Beltrami CA, Di Loreto C.

Anticancer Res. 2000 Jan-Feb;20(1A):311-6.

PMID:
10769673
[PubMed - indexed for MEDLINE]
16.

Role of the transitional mucosa of the colon in differentiating primary adenocarcinoma from carcinomas metastatic to the colon. An immunohistochemical study.

Sawady J, Friedman MI, Katzin WE, Mendelsohn G.

Am J Surg Pathol. 1991 Feb;15(2):136-44.

PMID:
1989461
[PubMed - indexed for MEDLINE]
17.

Expression of homeodomain protein CDX2 in colorectal adenoma and adenocarcinoma.

Bakaris S, Cetinkaya A, Ezberci F, Ekerbicer H.

Histol Histopathol. 2008 Sep;23(9):1043-7.

PMID:
18581275
[PubMed - indexed for MEDLINE]
18.

CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites.

De Lott LB, Morrison C, Suster S, Cohn DE, Frankel WL.

Arch Pathol Lab Med. 2005 Sep;129(9):1100-5.

PMID:
16119980
[PubMed - indexed for MEDLINE]
19.

CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.

La Rosa S, Rigoli E, Uccella S, Chiaravalli AM, Capella C.

Virchows Arch. 2004 Sep;445(3):248-54. Epub 2004 Jul 29.

PMID:
15517368
[PubMed - indexed for MEDLINE]
20.

The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.

Zheng HC, Zheng YS, Xia P, Xu XY, Xing YN, Takahashi H, Guan YF, Takano Y.

Histol Histopathol. 2010 Apr;25(4):445-52.

PMID:
20183797
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk